Maryland Capital Management Merck & Co., Inc. Transaction History

Maryland Capital Management

$1.2 Billion
Q3 2022

A detailed history of Maryland Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Maryland Capital Management holds 112,477 shares of MRK stock, worth $11.5 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares

112,477

Previous 103,430 8.75%

Holding current value

$11.5 Million

Previous $9.43 Million 2.73%

% of portfolio

0.81%

Previous 0.74%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $764,742 - $859,103	9,047 Added 8.75%	112,477 $9.69 Million
Q2 2022 Aug 11, 2022	BUY	$83.49 - $94.64 $430,975 - $488,531	5,162 Added 5.25%	103,430 $9.43 Million
Q1 2022 May 12, 2022	BUY	$73.51 - $82.4 $229,277 - $257,005	3,119 Added 3.28%	98,268 $8.06 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $173,399 - $217,205	2,399 Added 2.59%	95,149 $7.29 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $551,004 - $605,966	-7,687 Reduced 7.65%	92,750 $6.97 Million
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $244,327 - $270,250	3,475 Added 3.58%	100,437 $7.81 Million
Q1 2021 May 11, 2021	BUY	$68.86 - $81.11 $386,442 - $455,189	5,612 Added 6.14%	96,962 $7.47 Million
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $642,772 - $713,345	8,956 Added 10.87%	91,350 $7.47 Million
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $124,040 - $140,600	1,695 Added 2.1%	82,394 $6.84 Million
Q2 2020 Aug 12, 2020	BUY	$70.42 - $80.13 $328,298 - $373,566	4,662 Added 6.13%	80,699 $6.24 Million
Q1 2020 May 13, 2020	BUY	$63.36 - $87.82 $912,827 - $1.27 Million	14,407 Added 23.38%	76,037 $5.85 Million
Q4 2019 Feb 11, 2020	BUY	$77.58 - $87.54 $272,150 - $307,090	3,508 Added 6.04%	61,630 $5.61 Million
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $148,584 - $161,962	1,953 Added 3.48%	58,122 $4.89 Million
Q2 2019 Aug 13, 2019	BUY	$69.84 - $81.59 $309,880 - $362,014	4,437 Added 8.58%	56,169 $4.71 Million
Q1 2019 May 13, 2019	BUY	$69.58 - $79.36 $279,502 - $318,789	4,017 Added 8.42%	51,732 $4.3 Million
Q4 2018 Feb 13, 2019	BUY	$65.24 - $75.71 $153,574 - $178,221	2,354 Added 5.19%	47,715 $3.65 Million
Q3 2018 Nov 13, 2018	BUY	$57.69 - $67.84 $5,192 - $6,105	90 Added 0.2%	45,361 $3.22 Million
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $18,807 - $22,096	370 Added 0.82%	45,271 $2.75 Million
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $17,988 - $20,908	353 Added 0.79%	44,901 $2.45 Million
Q4 2017 Feb 13, 2018	BUY	$51.62 - $61.64 $118,726 - $141,772	2,300 Added 5.44%	44,548 $2.51 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $45,762 - $49,241	780 Added 1.88%	42,248 $2.71 Million
Q2 2017 Aug 14, 2017	BUY	N/A	41,468	41,468 $2.66 Million

Others Institutions Holding MRK

# of Institutions

3,808

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $258B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Maryland Capital Management with notifications on news.

Account

Maryland Capital Management Merck & Co., Inc. Transaction History